M6A-seq data of GBM and normal brain tissues

We depicted a transcriptome-wide m6A methylation profiling of lncRNAs in GBM for the first time, revealing the highly distinct m6A modification patterns of lncRNAs, compared to the normal brain tissues. And we identified m6A modified pseudogene HSPA7 as a novel risk prognostic factor for GBM patients, playing crucial roles in immunophenotype, stromal and carcinogenic pathways activation, having a robust predictive capacity of ICB immunotherapeutic response.